Hemosol
Executive Summary
Toronto, Canada blood substitute developer forms cross-linked hemoglobin R&D collaboration with the Dutch Red Cross, organizations announce Aug. 3. The Central Laboratory of the Netherlands Red Cross Blood Transfusion Service and Hemosol gain "reciprocal non-exclusive rights to each other's technology for research purposes," the groups explain.